Prevalence of Bronchiectasis in COPD Patients
Prevalence of and Prognostic Impact of Bronchiectasis in COPD Patients
1 other identifier
observational
100
1 country
1
Brief Summary
The identification of bronchiectasis in COPD has been defined as a different clinical COPD phenotype with greater symptomatic severity, more frequent chronic bronchial infection and exacerbations, and poor prognosis. A causal association has not yet been proven, but it is biologically plausible that COPD, and particularly the infective and exacerbator COPD phenotypes, could be the cause of bronchiectasis without any other known etiology, beyond any mere association or comorbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2019
CompletedFirst Posted
Study publicly available on registry
September 24, 2019
CompletedStudy Start
First participant enrolled
September 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedSeptember 24, 2019
September 1, 2019
11 months
September 22, 2019
September 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Bronchiectasis in COPD
percentage of bronchiectasis diagnosed by CT chest in COPD patients
1 year
Secondary Outcomes (3)
impact of bronchiectasis on COPD exacerbations
1 year
impact of bronchiectasis on COPD hospitalization
1 year
impact of bronchiectasis on COPD intensive care admission
1 year
Study Arms (2)
Group A
COPD patients with bronchiectasis
Group B
COPD patients without bronchiectasis
Interventions
percentage of bronchectasis in COPD and its effect as prognostic measure
Eligibility Criteria
COPD patients diagnosed based on GOLD criteria 2019 with chest CT finding of bronchiectasis
You may qualify if:
- COPD patients based on GOLD 2019 criteria, stable or in exacerbation
You may not qualify if:
- acute pneumonia within 2 months
- malignancy
- congenital bronchiectasis ( immobile cilia syndrome, Kartagnar syndrome).
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AssiutU
Asyut, 71111, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pulmonology
Study Record Dates
First Submitted
September 22, 2019
First Posted
September 24, 2019
Study Start
September 30, 2019
Primary Completion
September 1, 2020
Study Completion
September 30, 2020
Last Updated
September 24, 2019
Record last verified: 2019-09